Servier boosted
visibility & trust across sales hierarchies with Kennect
Prefer a PDF-Version?




Sales team strength
500+

Founded
1954

Industry
Pharmaceutical
Client Summary
Traditional spreadsheets couldn't keep up with one of the world's largest global pharmaceutical firms, which has a strong international presence in 150 countries and a total sales of 4.7 billion euros in 2021. Kennect was adopted by Servier to improve their commission process and reduce manual activities.
Kennect's user-friendly platform provides managers and administrators with access and transparency into the commission process, fostering trust and enhancing incentives across teams.

Key Results
- 87% of field forces track their incentives using the Kennect platform (based on Mar’2022 data).
- Kennect’s platform has helped SFE team in reducing the time spent on incentive calculation by upto 80%
- It has enabled the sales team to view their sales and incentives in real-time, previously they had to wait until the end of the month for the sales ops team to reveal their final performance
Challenges
Solutions
field force to plan and track their real-time
incentives
dashboards on mobile and web apps
Kennect web app
builder is provided to the admin team to update masters and create incentive plans

About Servier

Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and total revenue of 4.7 billion euros in 2021. Servier is an independent group that invests over 20% of its brand-name revenue in Research & Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient's voice at the heart of its activities
A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience, and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.